The Lancet HIV launched in September 2014 as an exclusively online journal, publishing original research, expert commentary, informative editorials, and timely correspondence. The monthly journal provides readers with context and insight into the clinical advances and practice-changing research shaping the study of HIV/AIDS today.

Now is a critical moment in the fight against HIV/AIDS. Despite the world view that the end of AIDS may be within reach, the job of controlling this epidemic is certainly not done. As HIV disease evolves to become a chronic infection, the interaction of the virus with other chronic conditions will present a host of new challenges. The Lancet HIV is a journal for a new era in the history of HIV/AIDS.

The Lancet HIV builds on The Lancet journals' reputation for publishing HIV/AIDS research to provide a reliable foundation for advocacy and for programmatic and political change. We will consider clinical, epidemiological, operational, and implementation research, unifying these disciplines across a single vision for the health of those living with HIV.

《柳叶刀艾滋病》于 2014 年 9 月作为一本纯在线期刊推出，发表原创研究、专家评论、信息丰富的社论和及时的通讯。该月刊为读者提供有关临床进展和改变实践的研究的背景和见解，这些研究正在影响当今的艾滋病研究。

现在是抗击艾滋病的关键时刻。尽管世界认为艾滋病的终结可能触手可及，但控制这一流行病的工作肯定尚未完成。随着艾滋病发展成为慢性感染，病毒与其他慢性疾病的相互作用将带来许多新挑战。《柳叶刀艾滋病》是一本开创艾滋病历史新纪元的期刊。

《柳叶刀艾滋病》以《柳叶刀》期刊发表艾滋病研究的声誉为基础，为宣传以及计划和政治变革提供了可靠的基础。我们将考虑临床、流行病学、操作和实施研究，将这些学科统一为艾滋病毒感染者的健康愿景。

该刊已被国际权威数据库SCIE收录，是国际顶级期刊。该刊致力于发表经过严格同行评审的高质量原创文章，反映IMMUNOLOGYINFECTIOUS DISEASES&-INFECTIOUS DISEASES领域的新进展、新技术、新成果，促进该领域科研交流和科研成果转化。该刊2023年影响因子为12.8，平均审稿速度为 ，近四年来没有被列入预警名单。如果您需要投稿发表服务及指导，可以联系我们的客服老师，我们专业专注服务期刊投稿协助10年，为您提供期刊投稿个性化定制服务，并且我们确保严格保密您的个人信息及稿件内容。